Bioxcel Therapeutics Inc (NASDAQ:BTAI) had a decrease of its short interest by 26.89%. In February was issued BTAI’s total 29,900 short interest by FINRA. The down change of 26.89% from 40,900 shares was reported. Former BTAI’s position will need 1 days to recover. It has 36,800 average volume. Float short on Bioxcel Therapeutics Inc is 0.5%.

BTAI is touching $5.38 during the last trading session, after increased 0.37%.BioXcel Therapeutics, Inc. has volume of 36,859 shares. Since February 2, 2018 BTAI has 0.00% and is . BTAI the S&P500 by 0.00%.

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence drug development in the fields of neuroscience and immuno-oncology in the United States.The firm is valued at $84.17 million. The firm is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers.Currently it has negative earnings. It is also developing BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immuno-oncology agent for hematological malignancies.

For more BioXcel Therapeutics, Inc. (NASDAQ:BTAI) news published recently go to: Benzinga.com, Schaeffersresearch.com, Nasdaq.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “58 Biggest Movers From Yesterday – Benzinga” published on January 09, 2019, “Drug Stock Soars After Strong Alzheimer’s Study Data – Schaeffers Research” on January 03, 2019, “Close Update: Apple Sales Warning Helps Push Investors Out of Stocks Sending Market Indexes Tumbling – Nasdaq” with a publish date: January 03, 2019, “Mid-Afternoon Market Update: Dow Down 575 Points; OHR Pharmaceutical Shares Spike Higher – Nasdaq” and the last “OPKO Health and Prana Biotechnology among healthcare gainers; Novus Therapeutics among losers – Seeking Alpha” with publication date: December 28, 2018.